Holding(s) in Company

RNS Number : 6411C

Spire Healthcare Group PLC

20 January 2015

TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Spire Healthcare Group plc

2. Reason for the notification (please state Yes/No):

An acquisition or disposal of voting rights:

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached:

An event changing the breakdown of voting rights: ( )

Other (please specify): Transfer of shares to 100% owned (in identical ratios) special purpose vehicle (Rozier Investments Limited Partnership)

3. Full name of person(s) subject to the notification obligation:

Cinven Limited
Cinven S.A

4. Full name of shareholder(s) (if different from 3.):

FOURTH CINVEN FUND (NO.1) LIMITED PARTNERSHIP

FOURTH CINVEN FUND (NO.2) LIMITED PARTNERSHIP

FOURTH CINVEN FUND (NO.3-VCOC) LIMITED PARTNERSHIP

FOURTH CINVEN FUND (NO.4) LIMITED PARTNERSHIP

FOURTH CINVEN FUND (UBTI) LIMITED PARTNERSHIP

FOURTH CINVEN FUND FCPR

FOURTH CINVEN FUND CO-INVESTMENT PARTNERSHIP

FOURTH CINVEN (MACIF) LIMITED PARTNERSHIP

5. Date of the transaction (and date on which the threshold is crossed or reached if different): 19 January 2015

6. Date on which issuer notified: 20 January 2015

7. Threshold(s) that is/are crossed or reached: The funds listed in 4 are no longer the registered holder of any shares in Spire Healthcare Group plc. Rozier Investments Limited Partnership is the registered holder of the shares previously held by the funds listed in 4, amounting to 48.35% of the voting rights in Spire Healthcare Group plc

8. Notified details:
A: Voting rights attached to shares ^{viii, ix}
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction		Resulting situation after the triggering transaction
	Number of Shares	Number of Voting Rights	Number of shares	Number of voting rights		% of voting rights ^x
	Number of Shares	Number of Voting Rights	Direct	Direct ^xi	Indirect ^xii	Direct	Indirect
ORDINARY ISIN: GB00BNLPYF73
FOURTH CINVEN FUND (NO.1) LIMITED PARTNERSHIP	37,706,919	37,706,919			37,706,919		9.401%
FOURTH CINVEN FUND (NO.2) LIMITED PARTNERSHIP	39,343,540	39,343,540			39,343,540		9.809%
FOURTH CINVEN FUND (NO.3-VCOC) LIMITED PARTNERSHIP	39,007,623	39,007,623			39,007,623		9.726%
FOURTH CINVEN FUND (NO.4) LIMITED PARTNERSHIP	37,226,578	37,226,578			37,226,578		9.282%
FOURTH CINVEN FUND (UBTI) LIMITED PARTNERSHIP	20,943,343	20,943,343			20,943,343		5.222%
FOURTH CINVEN FUND FCPR	17,231,332	17,231,332			17,231,332		4.296%
FOURTH CINVEN FUND CO-INVESTMENT PARTNERSHIP	1,914,593	1,914,593			1,914,593		0.477%
FOURTH CINVEN (MACIF) LIMITED PARTNERSHIP	547,872	547,872			547,872		0.137%
ROZIER INVESTMENTS LIMITED PARTNERSHIP	0	0		193,921,800		48.35%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration Date

Exercise/Conversion Period/ Date

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument	Exercise price	Expiration date	Exercise/Conversion period	Number of voting rights instrument refers to	% of voting rights
					Nominal	Delta

Total (A+B+C)

Number of voting rights	% of voting rights
193,921,800	48.350%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

Cinven Limited acts as manager of the following entities:

Fourth Cinven Fund (No.1) Limited Partnership

Fourth Cinven Fund (NO.2) Limited Partnership

Fourth Cinven Fund (NO.3-VCOC) Limited Partnership

Fourth Cinven Fund (NO.4) Limited Partnership

Fourth Cinven Fund ND (UBTI) Limited Partnership

Fourth Cinven (MACIF) Limited Partnership,

together the "Cinven Funds".

The Cinven Funds and Fourth Cinven Fund Co-Investment Partnership are party to an agreement whereby Fourth Cinven Fund Co-Investment Partnership acts in accordance with the actions of the Cinven Funds, meaning that Cinven Limited also effectively controls Fourth Cinven Fund Co-Investment Partnership.

Cinven S.A. acts as manager of Fourth Cinven Fund FCPR.

Cinven Funds and the FCPR are the beneficial owners of Rozier Investments Limited Partnership ("Rozier") which is now the registered holder of the shares as listed in section 8. The Cinven Funds' and the FCPR's interests in Rozier are exactly proportionate to the shares transferred.

Proxy Voting:

10. Name of the proxy holder: N/A

11. Number of voting rights proxy holder will cease to hold: N/A

12. Date on which proxy holder will cease to hold voting rights: N/A

13. Additional information: See box 9 above

14. Contact name:

Anthony Dand, Interim Deputy Secretary, Spire Healthcare Group plc

15. Contact telephone number:

+ 44 (0)20 7427 9092

This information is provided by RNS

The company news service from the London Stock Exchange

END